Wird geladen...
Megestrol acetate for cachexia–anorexia syndrome. A systematic review
In 1993, megestrol acetate (MA) was approved by the US Food and Drug Administration for the treatment of anorexia, cachexia, or unexplained weight loss in patients with acquired immunodeficiency syndrome. The mechanism by which MA increases appetite is unknown, and its effectiveness for anorexia and...
Gespeichert in:
| Veröffentlicht in: | J Cachexia Sarcopenia Muscle |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5989756/ https://ncbi.nlm.nih.gov/pubmed/29542279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jcsm.12292 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|